Finepoint Capital LP Spring Works Therapeutics, Inc. Transaction History
Finepoint Capital LP
- $963 Million
- Q3 2024
A detailed history of Finepoint Capital LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Finepoint Capital LP holds 650,852 shares of SWTX stock, worth $24 Million. This represents 2.17% of its overall portfolio holdings.
Number of Shares
650,852
Previous 638,352
1.96%
Holding current value
$24 Million
Previous $24 Million
13.28%
% of portfolio
2.17%
Previous 6.92%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$247 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$207 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$141 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$129 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$126 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.3B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...